Signature Engagement
The Preclinical Roadmap
A complete preclinical development plan from discovery through IND-enabling. Anchored in unmet need, built study-by-study, designed for regulatory alignment, and packaged to survive investor and pharma partner diligence.
What the Roadmap Includes
Four integrated components, delivered as one cohesive plan.
Unmet Need & Positioning
- Target rationale and indication selection
- Competitive landscape analysis
- Differentiation and strategic case
- Market opportunity assessment
Study-by-Study Plan
- Model selection with rationale
- Endpoint design and success criteria
- Timeline with milestones
- Budget with quarterly capital requirements
- CRO shortlists and recommendations
- Biomarker strategy
Regulatory Path
- IND/CTA regulatory strategy
- Dose rationale (MABEL/NOAEL framework)
- Pre-IND meeting strategy
- Nonclinical submission strategy and IND section outline
Diligence-Ready Package
- Visual timeline with milestones
- Risk assessment with mitigation plans
- Gap analysis
- Executive summary for board and investors
Who This Is For
The Roadmap is designed for teams ready to plan their path to the clinic.
Seed/Series A Biotech
You have a lead candidate ready for preclinical planning and need a complete development roadmap to guide execution and support fundraising.
Academic Spinouts
You're translating promising discovery work into a structured development plan that investors and partners can evaluate.
Multi-Program Companies
You need to plan a specific program's path to the clinic with study-level specificity, timelines, and budget clarity.
How to Start
Every engagement begins with a Strategy Call. Most companies start with a Diagnostic or go directly to a Roadmap.
Strategy Call
Complimentary · 30 minutes
Tell us about your program, your stage, and the decisions you're facing. We'll assess whether a Diagnostic or a full Roadmap is the right starting point.
Strategy Diagnostic
1-2 weeks
A focused assessment of where your program stands: readiness, competitive positioning, and strategic gaps. Tells you exactly what to prioritize next.
Preclinical Roadmap
2-4 weeks · The signature engagement
Unmet need analysis, study-by-study plan, regulatory path, and everything packaged for diligence.
What Makes This Different
The combination of operator experience, acquirer-side diligence perspective, and execution speed.
Operator-to-Acquirer Lens
Our founder has designed IND-enabling programs and evaluated companies from the acquirer side, supporting diligence on transactions valued up to $11B. We build plans that answer the questions the other side of the table actually asks.
Study-Level Specificity
Specific models, endpoints, budgets, and CRO shortlists for each study. Not abstract strategy decks. Plans your team can execute and your investors can evaluate.
2-4 Week Delivery
Most comparable preclinical roadmaps take 6-8+ weeks at other firms. We deliver faster without sacrificing depth because this is all we do.
Ready to Build Your Development Plan?
Book a Strategy Call. Complimentary, 30 minutes, no obligation.
Book a Strategy Call30-minute call · No obligation · Confidential
info@bridgelinetranslational.com · bridgelinetranslational.com